Compounded semaglutide is a customized formulation prepared by a licensed compounding pharmacy and prescribed by a qualified healthcare provider. It is designed to support weight management when combined with a reduced-calorie diet and healthy lifestyle habits.
Semaglutide belongs to a class of medications known as GLP-1 receptor agonists, which play an important role in appetite regulation and metabolic function. Compounded formulations allow for individualized dosing as determined by a licensed provider following a telehealth evaluation.
Semaglutide works by mimicking a naturally occurring hormone called GLP-1 (glucagon-like peptide-1), which helps regulate appetite and blood sugar levels.
This medication may support weight management by:
Reducing appetite and hunger signals
Increasing feelings of fullness after meals
Slowing gastric emptying to help reduce food intake
Supporting healthy blood sugar regulation
These effects may help patients develop healthier eating patterns over time.
All patients must complete an online intake form and undergo review by a licensed healthcare provider before starting treatment. Eligibility is determined based on medical history, current health status, and clinical guidelines.
Compounded semaglutide is available by prescription only and requires medical approval. Ongoing follow-up and support may be provided as part of the program.
Compounded semaglutide is not FDA-approved; however, it is prepared by licensed compounding pharmacies in accordance with applicable regulations. Individual results may vary.
Semaglutide may not be appropriate for individuals who:
Have a personal or family history of medullary thyroid carcinoma (MTC)
Have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Are pregnant, breastfeeding, or planning to become pregnant
Have certain gastrointestinal conditions or a history of pancreatitis
A licensed healthcare provider will determine eligibility based on medical evaluation.
